By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Vermillion today said that Medicare will cover its OVA1 test for help in determining the likelihood that an ovarian mass is benign or malignant.

Highmark Medicare Services is the CMS contractor that will process Medicare claims for OVA1.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Changing the fat and fiber content of people's diets affects their gut microbiome, metabolome, and colon cancer risk, researchers say.

Broken links are found throughout academic publications, and some services are trying to combat such link decay.

Nick Stockton at Wired says that a pause in studying genome-editing tools should be used to find a path forward.

In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.